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Background
The soluble guanylyl cyclase (sGC) is expressed in airway
smooth muscle, and agents that stimulate sGC activity
cause airway smooth muscle relaxation and bronchodila-
tion. BAY 41-2272 is a potent nitric oxide (NO)-inde-
pendent sGC stimulator, but little is known about its
effects in airway smooth muscle. Therefore, this study
aimed to investigate the mechanisms underlying the relax-
ations of rat tracheal smooth muscle induced by BAY 41-
2272.
Methods
Tracheal rings were mounted in 10-ml organ baths for iso-
metric force recording. BAY 41-2272 (0.0001–100 μM)
concentration-dependently relaxed carbachol-precon-
tracted tracheal rings (pEC50 = 6.68 ± 0.14).
Results
The NO synthesis inhibitor L-NAME (100 μM) and the
sGC inhibitor ODQ (10 μM) caused significant rightward
shifts in the concentration-response curves to BAY 41-
2272. In addition, BAY 41-2272 (0.01 and 0.1 μM)
increased the cGMP levels (approximately 2.2- and 4.2-
fold, respectively), and significantly potentiated the
sodium nitroprusside-induced relaxations. At the higher
concentrations (0.03–1 μM), BAY 41-2272 shifted to the
right the tracheal contractile responses to either carbachol
(0.001–10 μM) or electrical field stimulation (EFS, 1–32
Hz). BAY 41-2272 (1 and 10 μM) also caused a marked
rightward shift and decreased the maximal contractile
responses to extracellular CaCl2.
Conclusion
Our results indicate that BAY 41-2272 potently relaxes the
rat tracheal smooth muscle in a synergistic fashion with
exogenous NO. BAY 41-2272, at higher concentrations,
has an additional mechanism involving Ca2+ entry block-
ade.
from 4th International Conference of cGMP Generators, Effectors and Therapeutic Implications
Regensburg, Germany. 19–21 June 2009
Published: 11 August 2009
BMC Pharmacology 2009, 9(Suppl 1):P68 doi:10.1186/1471-2210-9-S1-P68
<supplement> <title> <p>4th International Conference of cGMP Generators, Effectors and Therapeutic Implications</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1471-2210-9-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2210-9-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.biomedcentral.com/1471-2210/9/S1/P68
© 2009 Toque et al; licensee BioMed Central Ltd. 